Virodhamine
Discontinued Product
Chemical Name: O-(2-Aminoethyl)-5Z,8Z,11Z,14Z-eicosatetraenoate
Biological Activity
Endogenous cannabinoid receptor mixed agonist/antagonist found in higher concentrations peripherally than anandamide. Full agonist at GPR55 and CB2 and partial agonist/antagonist at CB1 (EC50 values are 12, 381 and 2920 nM at GPR55, CB2 and CB1 receptors respectively). Induces hypothermia in vivo.Technical Data
The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Background References
-
Olanzapine: preclinical and clinical profiles of a novel antipsychotic agent.
Tollefson and Taylor
CNS Drug Reviews, 2000;6:303 -
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter et al.
J.Pharmacol.Exp.Ther., 2002;301:1020 -
The orphan receptor GPR55 is a novel cannabinoid receptor.
Ryberg et al.
Br.J.Pharmacol., 2007;152:1092 -
Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor.
Porter et al.
J.Pharmacol.Exp.Ther., 2002;301:1020 -
Further characterization of the novel endocannabinoid virodhamine.
Sauer et al.
2002 Symposium on the Cannabinoids, International, 2002;
Product Datasheets
Reconstitution Calculator
Molarity Calculator
FAQs
No product specific FAQs exist for this product, however you may
View all Small Molecule FAQsReviews for Virodhamine
There are currently no reviews for this product. Be the first to review Virodhamine and earn rewards!
Have you used Virodhamine?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
